Temasek led an investment round in Ceva Sante Animale.

Temasek led an investment round in Ceva Sante Animale, a multinational animal health company based in Libourne, France. New investors joining the funding round include France's EMZ, Sagard, Archimed, China's HOPU Investments and US-based Continental Grain Company. Reinvesting in this round are French shareholders Sofiproteol, Merieux Equity Partners, France's Téthys Invest, Canada's PSP Investments, Japan's Mitsui & Co and Germany's Klocke Gruppe. Financial terms were not disclosed. "I am delighted to see that in this new round of financing, the management's participation, supported by the 'Friends of Ceva', is being strengthened alongside our historic financial investors and new entrants. Ceva plays a major role in animal health, particularly in the fight against emerging diseases, sometimes zoonotic, and in the treatment of chronic diseases affecting our loyal four-legged companions. At Ceva, we are convinced that we must continue to create bridges between different health sectors to protect the health of ecosystems and humans as well as global food security," Marc Prikazsky, Ceva Animal Health Chairman and CEO.